Search companies or stocks...
PRTAProthena Corporation plc
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The…
Current stock price of Prothena Corporation plc (PRTA) stock is $9.690. The stock price is +0.78% higher in the session. The intraday range can be seen from this page. Volume of Prothena Corporation plc (PRTA) stock is 341.05K.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of Prothena Corporation plc (PRTA) can change with earnings, company news, and overall market sentiment. Prothena Corporation plc operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Prothena Corporation plc looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PRTA on this page is -11.67. EPS on this page is -0.83. Compare those figures with peers and growth expectations before deciding if the current Prothena Corporation plc price is justified.
Historical performance for Prothena Corporation plc (PRTA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PRTA reacted to past earnings and market events.
Buying Prothena Corporation plc (PRTA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
